Read + Share
Vuorio A, Kovanen PT. PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of
interferon in patients with hypercholesterolemia. J Intern Med 2020 Nov 21. doi: 10.1111/joim.13210.
PMID: 33222314
|
 |
|
Vuorio A, Kovanen PT. PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of
interferon in patients with hypercholesterolemia. J Intern Med 2020 Nov 21. doi: 10.1111/joim.13210.
PMID: 33222314
|
|
|
|